Indonesia seeks to launch homegrown Covid-19 vaccine in 3rd quarter

  • 📰 STForeignDesk
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 71%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

JAKARTA - Indonesia will seek to launch a homegrown Covid-19 vaccine in August, with the first phase of clinical trials for the Merah Putih vaccine now underway.

Analysts said it was an important development for Indonesia, where more than 65 per cent of the eligible population have been fully vaccinated against Covid-19, if a vaccine can be produced domestically from a trusted source.

Professor Fedik Abdul Rantam, who leads Airlangga University's vaccine research team, told The Straits Times the vaccine will protect humans from existing coronavirus variants. He did not mention any specific variant. Indonesia, the world's fourth most populous nation of 270 million, has so far relied on foreign vaccines,mainly the Chinese-made Sinovac, that it purchased or received as donations for its vaccination campaign.

Biotis Pharmaceuticals Indonesia president director FX Sudirman told The Straits Times the company will initially focus on providing booster jabs for children.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Timing your booster after a Covid-19 infectionNEW YORK — Millions of people who have recently developed Covid-19 may have some new questions about their immunity. If they have not yet received a booster shot, do they still need to get one? And when is the optimal time to get it? In Pfizer scientists’ own honest words off the record:
Source: TODAYonline - 🏆 1. / 99 Read more »

Hong Kong working-class district reels as Covid-19 runs rampant
Source: STForeignDesk - 🏆 4. / 71 Read more »

A Covid-19 pill from Merck shows promise in reducing the risk of hospitalisation
Source: STForeignDesk - 🏆 4. / 71 Read more »

Commentary: Just how concerned should we be about COVID-19 reinfections?Reports of COVID-19 reinfection have become common since the Omicron variant emerged, but many cases are still likely to go undiagnosed, says a medical professor.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Pre-schools grappling with Covid-19 rules as more children, staff infected
Source: straits_times - 🏆 5. / 69 Read more »